Skip to ContentSkip to Navigation
How to find us prof. dr. E.M.D. (Ed) Schuuring


Detecting therapy-guiding RNA aberrations in platelets of non-small cell lung cancer patients

DNA methylation markers as triage test for the early identification of cervical lesions in a Chinese population

First-in-Human Phase I Clinical Trial of an SFV-Based RNA Replicon Cancer Vaccine against HPV-Induced Cancers

Lung Cancer in the Netherlands

Non-small-cell lung cancer infiltrated with chronic myelomonocytic leukaemia: a molecular diagnostic challenge to recognise mixed cancers in a single biopsy

"The leading role of pathology in assessing the somatic molecular alterations of cancer: Position Paper of the European Society of Pathology": letter to the Editor

An All-In-One Transcriptome-Based Assay to Identify Therapy-Guiding Genomic Aberrations in Nonsmall Cell Lung Cancer Patients

Biological tumor markers associated with local control after primary radiotherapy in laryngeal cancer: A systematic review

Biomarker testing in oncology - Requirements for organizing external quality assessment programs to improve the performance of laboratory testing: revision of an expert opinion paper on behalf of IQNPath ABSL

Causes behind error rates for predictive biomarker testing: the utility of sending post-EQA surveys

Read more


“Betere diagnostiek verhoogt overlevingskans”

“Celvrij DNA-onderzoek nog niet klaar voor kliniek”

diagnostisch onderzoek naar longkanker kan nieuwe/betere behandelmethode bieden

Gezamenlijke visie Groningen op biomarkers, bioanalyse en diagnostiek heeft nationaal zijn weerga

UMCG ontvangt 4 ton subsidie voor onderzoek baarmoederhalskanker

UMCG krijgt vier ton subsidie voor verbetering onderzoek naar baarmoederhalskanker.

Bepalen van mate van testen bij patienten met ntrk-genfusies

Behandelingen op maat van kankerpatienten zit in stroomversnelling

Read more